Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Brugia malayi in Mastomys natalensis: efficacy of mebendazole in combination with Freund's complete adjuvant.

Identifieur interne : 00D162 ( Main/Exploration ); précédent : 00D161; suivant : 00D163

Brugia malayi in Mastomys natalensis: efficacy of mebendazole in combination with Freund's complete adjuvant.

Auteurs : P K Murthy [Inde] ; K. Tyagi ; R K Chatterjee

Source :

RBID : pubmed:1644349

Descripteurs français

English descriptors

Abstract

The chemotherapeutic efficacy of mebendazole given in combination with Freund's complete adjuvant (FCA) against Brugia malayi in multimammate rat was evaluated. Animals treated with mebendazole, orally at 200 mg/kg x 5 consecutive days along with FCA given subcutaneously (s.c.) on day -10, day 0 and day +15 of the drug treatment killed 48.51% of the adult worms. This drug given alone at the same regimen and by the same route showed only 18.7% mortality rate on adults. Mebendazole given intraperitoneally along with FCA given s.c., however, was four times more efficacious as filaricide than mebendazole alone. Nevertheless, the animals receiving FCA alone also revealed 23.5% mortality rate of adult worms. The animals receiving a combination therapy or FCA alone showed significant increase in antibody titre to the filariae which however decreased in the later stages. No enhancement of antibody level could be detected in animals treated with mebendazole alone. The non-specific immunopotentiation induced by FCA appeared to play a major role in enhancing the activity of mebendazole.

PubMed: 1644349


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Brugia malayi in Mastomys natalensis: efficacy of mebendazole in combination with Freund's complete adjuvant.</title>
<author>
<name sortKey="Murthy, P K" sort="Murthy, P K" uniqKey="Murthy P" first="P K" last="Murthy">P K Murthy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Parasitology, Central Drug Research Institute, Lucknow, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Parasitology, Central Drug Research Institute, Lucknow</wicri:regionArea>
<wicri:noRegion>Lucknow</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tyagi, K" sort="Tyagi, K" uniqKey="Tyagi K" first="K" last="Tyagi">K. Tyagi</name>
</author>
<author>
<name sortKey="Chatterjee, R K" sort="Chatterjee, R K" uniqKey="Chatterjee R" first="R K" last="Chatterjee">R K Chatterjee</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1992">1992</date>
<idno type="RBID">pubmed:1644349</idno>
<idno type="pmid">1644349</idno>
<idno type="wicri:Area/PubMed/Corpus">005992</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005992</idno>
<idno type="wicri:Area/PubMed/Curation">005992</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005992</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005992</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005992</idno>
<idno type="wicri:Area/Ncbi/Merge">002109</idno>
<idno type="wicri:Area/Ncbi/Curation">002109</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002109</idno>
<idno type="wicri:doubleKey">0015-5683:1992:Murthy P:brugia:malayi:in</idno>
<idno type="wicri:Area/Main/Merge">00DC53</idno>
<idno type="wicri:Area/Main/Curation">00D162</idno>
<idno type="wicri:Area/Main/Exploration">00D162</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Brugia malayi in Mastomys natalensis: efficacy of mebendazole in combination with Freund's complete adjuvant.</title>
<author>
<name sortKey="Murthy, P K" sort="Murthy, P K" uniqKey="Murthy P" first="P K" last="Murthy">P K Murthy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Parasitology, Central Drug Research Institute, Lucknow, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Parasitology, Central Drug Research Institute, Lucknow</wicri:regionArea>
<wicri:noRegion>Lucknow</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tyagi, K" sort="Tyagi, K" uniqKey="Tyagi K" first="K" last="Tyagi">K. Tyagi</name>
</author>
<author>
<name sortKey="Chatterjee, R K" sort="Chatterjee, R K" uniqKey="Chatterjee R" first="R K" last="Chatterjee">R K Chatterjee</name>
</author>
</analytic>
<series>
<title level="j">Folia parasitologica</title>
<idno type="ISSN">0015-5683</idno>
<imprint>
<date when="1992" type="published">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Administration, Oral</term>
<term>Animals</term>
<term>Antibodies, Helminth (biosynthesis)</term>
<term>Brugia (drug effects)</term>
<term>Brugia (immunology)</term>
<term>Elephantiasis, Filarial (blood)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Freund's Adjuvant (administration & dosage)</term>
<term>Freund's Adjuvant (therapeutic use)</term>
<term>Injections, Intraperitoneal</term>
<term>Injections, Subcutaneous</term>
<term>Mebendazole (administration & dosage)</term>
<term>Mebendazole (pharmacology)</term>
<term>Mebendazole (therapeutic use)</term>
<term>Microfilariae (drug effects)</term>
<term>Muridae</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adjuvant Freund (administration et posologie)</term>
<term>Adjuvant Freund (usage thérapeutique)</term>
<term>Administration par voie orale</term>
<term>Animaux</term>
<term>Anticorps antihelminthe (biosynthèse)</term>
<term>Brugia ()</term>
<term>Brugia (immunologie)</term>
<term>Filariose lymphatique (sang)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Injections péritoneales</term>
<term>Injections sous-cutanées</term>
<term>Microfilaria ()</term>
<term>Muridae</term>
<term>Mébendazole (administration et posologie)</term>
<term>Mébendazole (pharmacologie)</term>
<term>Mébendazole (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Freund's Adjuvant</term>
<term>Mebendazole</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Antibodies, Helminth</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Adjuvant Freund</term>
<term>Mébendazole</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Anticorps antihelminthe</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Brugia</term>
<term>Microfilariae</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Brugia</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Brugia</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Mébendazole</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Mebendazole</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Freund's Adjuvant</term>
<term>Mebendazole</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Adjuvant Freund</term>
<term>Mébendazole</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Administration, Oral</term>
<term>Animals</term>
<term>Injections, Intraperitoneal</term>
<term>Injections, Subcutaneous</term>
<term>Muridae</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Administration par voie orale</term>
<term>Animaux</term>
<term>Brugia</term>
<term>Injections péritoneales</term>
<term>Injections sous-cutanées</term>
<term>Microfilaria</term>
<term>Muridae</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The chemotherapeutic efficacy of mebendazole given in combination with Freund's complete adjuvant (FCA) against Brugia malayi in multimammate rat was evaluated. Animals treated with mebendazole, orally at 200 mg/kg x 5 consecutive days along with FCA given subcutaneously (s.c.) on day -10, day 0 and day +15 of the drug treatment killed 48.51% of the adult worms. This drug given alone at the same regimen and by the same route showed only 18.7% mortality rate on adults. Mebendazole given intraperitoneally along with FCA given s.c., however, was four times more efficacious as filaricide than mebendazole alone. Nevertheless, the animals receiving FCA alone also revealed 23.5% mortality rate of adult worms. The animals receiving a combination therapy or FCA alone showed significant increase in antibody titre to the filariae which however decreased in the later stages. No enhancement of antibody level could be detected in animals treated with mebendazole alone. The non-specific immunopotentiation induced by FCA appeared to play a major role in enhancing the activity of mebendazole.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Chatterjee, R K" sort="Chatterjee, R K" uniqKey="Chatterjee R" first="R K" last="Chatterjee">R K Chatterjee</name>
<name sortKey="Tyagi, K" sort="Tyagi, K" uniqKey="Tyagi K" first="K" last="Tyagi">K. Tyagi</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Murthy, P K" sort="Murthy, P K" uniqKey="Murthy P" first="P K" last="Murthy">P K Murthy</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00D162 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00D162 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:1644349
   |texte=   Brugia malayi in Mastomys natalensis: efficacy of mebendazole in combination with Freund's complete adjuvant.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:1644349" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024